과제정보
This study was supported by the science and Technology Development Plant of Jilin Province (No.20180101015JC), the research grant from the Jilin Province Science and Technology Development Plan Project (NO.20190303182SF).
참고문헌
- Lane BR, Kattan MW. Predicting outcomes in renal cell carcinoma. Curr Opin Urol 2005;15:289-297 https://doi.org/10.1097/01.mou.0000178336.94991.17
- Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics 2001;21:S237-S254 https://doi.org/10.1148/radiographics.21.suppl_1.g01oc18s237
- Tsui KH, Shvarts O, Smith RB, Figlin R, de Kernion JB, Belldegrun A. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000;163:426-430 https://doi.org/10.1016/S0022-5347(05)67892-5
- Rabjerg M, Mikkelsen MN, Walter S, Marcussen N. Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study. APMIS 2014;122:708-714 https://doi.org/10.1111/apm.12282
- Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331-1334 https://doi.org/10.1093/jnci/djj362
- Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 2010;183:1309-1315 https://doi.org/10.1016/j.juro.2009.12.035
- Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 2013;37:1490-1504 https://doi.org/10.1097/PAS.0b013e318299f0fb
- Klatte T, Kroeger N, Zimmermann U, Burchardt M, Belldegrun AS, Pantuck AJ. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol 2014;32:597-605 https://doi.org/10.1007/s00345-014-1284-7
- Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010;58:398-406 https://doi.org/10.1016/j.eururo.2010.06.032
- Amtrup F, Hansen JB, Thybo E. Prognosis in renal carcinoma evaluated from histological criteria. Scand J Urol Nephrol 1974;8:198-202 https://doi.org/10.3109/00365597409132129
- Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005;104:511-520 https://doi.org/10.1002/cncr.21206
- Zhang L, Zha Z, Qu W, Zhao H, Yuan J, Feng Y, et al. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis. BMC Cancer 2018;18:870
- Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Coughlin G, Dunglison N, et al. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma. Histopathology 2019;74:284-290 https://doi.org/10.1111/his.13737
- Ficarra V, Brunelli M, Novara G, D'Elia C, Segala D, Gardiman M, et al. Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours. Pathology 2011;43:149-155 https://doi.org/10.1097/PAT.0b013e32834317a4
- Mally AD, Gayed B, Averch T, Davies B. The current role of percutaneous biopsy of renal masses. Can J Urol 2012;19:6243-6249
- Herts BR, Coll DM, Novick AC, Obuchowski N, Linnell G, Wirth SL, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 2002;178:367-372 https://doi.org/10.2214/ajr.178.2.1780367
- Choi SY, Sung DJ, Yang KS, Kim KA, Yeom SK, Sim KC, et al. Small (< 4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade. Abdom Radiol (NY) 2016;41:1160-1169 https://doi.org/10.1007/s00261-016-0732-9
- Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441-446 https://doi.org/10.1016/j.ejca.2011.11.036
- Ding J, Xing Z, Jiang Z, Chen J, Pan L, Qiu J, et al. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma. Eur J Radiol 2018;103:51-56 https://doi.org/10.1016/j.ejrad.2018.04.013
- Zhang X, Xu X, Tian Q, Li B, Wu Y, Yang Z, et al. Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging. J Magn Reson Imaging 2017;46:1281-1288 https://doi.org/10.1002/jmri.25669
- Zhu X, Dong D, Chen Z, Fang M, Zhang L, Song J, et al. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer. Eur Radiol 2018;28:2772-2778 https://doi.org/10.1007/s00330-017-5221-1
- Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27:v38-v49 https://doi.org/10.1093/annonc/mdw350
- Tsili AC, Argyropoulou MI, Gousia A, Kalef-Ezra J, Sofikitis N, Malamou-Mitsi V, et al. Renal cell carcinoma: value of multiphase MDCT with multiplanar reformations in the detection of pseudocapsule. AJR Am J Roentgenol 2012;199:379-386 https://doi.org/10.2214/AJR.11.7747
- Schiavina R, Borghesi M, Chessa F, Dababneh H, Bianchi L, Della Mora L, et al. The prognostic impact of tumor size on cancer-specific and overall survival among patients with pathologic T3a renal cell carcinoma. Clin Genitourin Cancer 2015;13:e235-e241 https://doi.org/10.1016/j.clgc.2014.06.011
- Cho S, Lee JH, Jeon SH, Park J, Lee SH, Kim CH, et al. A prospective, multicenter analysis of pseudocapsule characteristics: do all stages of renal cell carcinoma have complete pseudocapsules? Urol Oncol 2017;35:370-378 https://doi.org/10.1016/j.urolonc.2017.01.003
- Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 2013;266:177-184 https://doi.org/10.1148/radiol.12120254
- Ng F, Kozarski R, Ganeshan B, Goh V. Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 2013;82:342-348 https://doi.org/10.1016/j.ejrad.2012.10.023
- Brinker DA, Amin MB, de Peralta-Venturina M, Reuter V, Chan DY, Epstein JI. Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol 2000;24:988-995 https://doi.org/10.1097/00000478-200007000-00010
- Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, et al. Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: a study of 842 consecutive cases from a single institution. Am J Surg Pathol 2016;40:1224-1231 https://doi.org/10.1097/PAS.0000000000000690